AI assistant
Sending…
WEYCO GROUP INC — Director's Dealing 2014
Aug 27, 2014
33363_dirs_2014-08-27_6b8a4f30-5a1d-4d29-9db6-3a6746f0f5fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEYCO GROUP INC (WEYS)
CIK: 0000106532
Period of Report: 2014-08-26
Reporting Person: FLORSHEIM JOHN W (Director, President and COO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-08-26 | Stock Option | $27.04 | A | 40000 | Acquired | 2020-08-26 | Common Stock (40000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 196209 | Direct |
| Common Stock | 62497 | Indirect |
| Common Stock | 223596 | Indirect |
| Common Stock | 200000 | Indirect |
| Common Stock | 12440 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $18.03 | 2015-04-26 | Common Stock (19958) | 19958 | Direct |
| Stock Option | $23.09 | 2014-12-01 | Common Stock (30000) | 30000 | Direct |
| Stock Option | $24.49 | 2015-12-01 | Common Stock (30000) | 30000 | Direct |
| Stock Option | $24.21 | 2017-12-01 | Common Stock (32500) | 32500 | Direct |
| Stock Option | $23.53 | 2008-12-01 | Common Stock (32500) | 32500 | Direct |
| Stock Option | $28.5 | 2019-12-02 | Common Stock (40000) | 40000 | Direct |
Footnotes
F1: For Informational Purposes
F2: 25% per year for 4 years beginning 12/01/2010
F3: 25% per year for 4 years beginning 12/01/2011
F4: 25% per year for 4 years beginning 12/01/2012
F5: 25% per year for 4 years beginning 12/01/2013
F6: 25% per year for 4 years beginning 12/02/2014
F7: 25% per year for 4 years beginning 08/26/2015
More from WEYCO GROUP INC
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Annual Report
2026
Mar 13
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 1